Please enable JavaScript to continue using this application.

Compare tickers

Valuation, margins, and growth side by side.

Compare $BDSX vs $INFU | Chartloom

Compare

$BDSX vs $INFU

Biodesix Inc · InfuSystem Holdings Inc

BDSX

Biodesix Inc

INFU

InfuSystem Holdings Inc

Compare $BDSX vs $INFU

Comparing Biodesix Inc and InfuSystem Holdings Inc

BDSXBiodesix Inc

INFUInfuSystem Holdings Inc

BDSXBiodesix Inc

Market cap

$249M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

2.00x

Rev growth (TTM)

34.5%

YTD performance

271.4%

52W performance

224.2%

FCF yield

-8.2%

INFUInfuSystem Holdings Inc

Market cap

$274M

P/E (TTM)

33.30x

Forward P/E (NTM)

27.59x

Forward P/S (NTM)

1.80x

Rev growth (TTM)

2.5%

YTD performance

62.1%

52W performance

47.5%

FCF yield

4.6%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

BDSX

INFU

Detailed metrics comparison

BDSX

Biodesix Inc

INFU

InfuSystem Holdings Inc

Market Cap

BDSX$249M

INFU$274M

Enterprise Value

BDSX$265M

INFU$294M

Price

BDSX$23.99

INFU$13.60

P/E Ratio

BDSXN/A

INFU33.30x

P/S Ratio

BDSX2.41x

INFU1.91x

EV/Sales

BDSX2.58x

INFU2.05x

EV/EBITDA

BDSX0.00x

INFU11.16x

P/B Ratio

BDSX30.02x

INFU4.57x

P/FCF Ratio

BDSXN/A

INFU21.87x

EV/FCF

BDSX-13.01x

INFU23.42x

PEG Ratio

BDSXN/A

INFU0.46x

Forward P/E (NTM)

BDSXN/A

INFU27.59x

Forward P/S (NTM)

BDSX2.00x

INFU1.80x

Revenue (TTM)

BDSX$103M

INFU$143M

Revenue Growth (YoY)

BDSX34.5%

INFU2.5%

Forward Rev Growth

BDSX20.2%

INFU6.2%

Gross Margin (TTM)

BDSX82.5%

INFU57.5%

Operating Margin (TTM)

BDSX0.0%

INFU9.3%

EBITDA Margin (TTM)

BDSX-14.6%

INFU18.4%

Net Margin (TTM)

BDSX-27.0%

INFU6.0%

FCF Margin (TTM)

BDSX-19.8%

INFU8.8%

Net Income (TTM)

BDSX$-28M

INFU$9M

FCF (TTM)

BDSX$-20M

INFU$13M

EPS (TTM)

BDSX-$2.70

INFU$0.41

ROE (TTM)

BDSX-16487.0%

INFU14.8%

ROA (TTM)

BDSX-3033.0%

INFU8.6%

ROIC (TTM)

BDSX-2700.0%

INFU11.0%

Cash

BDSX$30M

INFU$964K

Debt

BDSX$47M

INFU$20M

Net Cash/Debt

BDSX$-17M

INFU$-19M

Current Ratio (TTM)

BDSX2.85x

INFU2.50x

Quick Ratio (TTM)

BDSX2.85x

INFU2.14x

Debt/Equity (TTM)

BDSX5.12x

INFU0.35x

Debt/Assets (TTM)

BDSX0.0%

INFU0.0%

Interest Coverage (TTM)

BDSXN/A

INFUN/A

Net Debt/EBITDA (TTM)

BDSX0.00x

INFU0.00x

Beta

BDSX0.60

INFU1.43

52W Performance

BDSX224.2%

INFU47.5%

YTD Performance

BDSX271.4%

INFU62.1%

% from 52W High

BDSX-25.0%

INFU-1.8%

% from 52W Low

BDSX356.1%

INFU86.6%

Asset Turnover (TTM)

BDSX1.12x

INFU1.45x

FCF Yield (TTM)

BDSX-8.2%

INFU4.6%

Earnings Yield (TTM)

BDSX-11.2%

INFU3.1%

Dividend Yield (TTM)

BDSXN/A

INFUN/A

Rule of 40

BDSX14.6

INFU11.2

EV/GP/RG

BDSX0.15

INFU0.58

Ticker research

View BDSX research View INFU research

Metric	BDSX Biodesix Inc	INFU InfuSystem Holdings Inc
Market & Valuation
Market Cap	$249M	$274M
Enterprise Value	$265M	$294M
Price	$23.99	$13.60
P/E Ratio	N/A	33.30x
P/S Ratio	2.41x	1.91x
EV/Sales	2.58x	2.05x
EV/EBITDA	0.00x	11.16x
P/B Ratio	30.02x	4.57x
P/FCF Ratio	N/A	21.87x
EV/FCF	-13.01x	23.42x
PEG Ratio	N/A	0.46x
Forward P/E (NTM)	N/A	27.59x
Forward P/S (NTM)	2.00x	1.80x
Revenue & Growth
Revenue (TTM)	$103M	$143M
Revenue Growth (YoY)	34.5%	2.5%
Forward Rev Growth	20.2%	6.2%
Profitability
Gross Margin (TTM)	82.5%	57.5%
Operating Margin (TTM)	0.0%	9.3%
EBITDA Margin (TTM)	-14.6%	18.4%
Net Margin (TTM)	-27.0%	6.0%
FCF Margin (TTM)	-19.8%	8.8%
Net Income (TTM)	$-28M	$9M
FCF (TTM)	$-20M	$13M
EPS (TTM)	-$2.70	$0.41
ROE (TTM)	-16487.0%	14.8%
ROA (TTM)	-3033.0%	8.6%
ROIC (TTM)	-2700.0%	11.0%
Financial Health
Cash	$30M	$964K
Debt	$47M	$20M
Net Cash/Debt	$-17M	$-19M
Current Ratio (TTM)	2.85x	2.50x
Quick Ratio (TTM)	2.85x	2.14x
Debt/Equity (TTM)	5.12x	0.35x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.60	1.43
52W Performance	224.2%	47.5%
YTD Performance	271.4%	62.1%
% from 52W High	-25.0%	-1.8%
% from 52W Low	356.1%	86.6%
Efficiency & Yields
Asset Turnover (TTM)	1.12x	1.45x
FCF Yield (TTM)	-8.2%	4.6%
Earnings Yield (TTM)	-11.2%	3.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	14.6	11.2
EV/GP/RG	0.15	0.58
Ticker research	View BDSX research	View INFU research

Valuation

P/E Ratio

INFU

33.30x

P/S Ratio

INFU

1.91x

BDSX

2.41x

EV/FCF

BDSX

-13.01x

INFU

23.42x

Growth & revenue

Revenue Growth TTM

BDSX

34.5%

INFU

2.5%

Forward Revenue Growth

BDSX

20.2%

INFU

6.2%

Profitability & performance

Gross Margin

BDSX

82.5%

INFU

57.5%

ROE

INFU

14.8%

BDSX

-16487.0%

FCF Yield %

INFU

4.6%

BDSX

-8.2%

52-Week Performance

BDSX

224.2%

INFU

47.5%

Detailed metrics comparison

BDSX

Biodesix Inc

INFU

InfuSystem Holdings Inc

Market Cap

BDSX$249M

INFU$274M

Enterprise Value

BDSX$265M

INFU$294M

Price

BDSX$23.99

INFU$13.60

P/E Ratio

BDSXN/A

INFU33.30x

P/S Ratio

BDSX2.41x

INFU1.91x

EV/Sales

BDSX2.58x

INFU2.05x

EV/EBITDA

BDSX0.00x

INFU11.16x

P/B Ratio

BDSX30.02x

INFU4.57x

P/FCF Ratio

BDSXN/A

INFU21.87x

EV/FCF

BDSX-13.01x

INFU23.42x

PEG Ratio

BDSXN/A

INFU0.46x

Forward P/E (NTM)

BDSXN/A

INFU27.59x

Forward P/S (NTM)

BDSX2.00x

INFU1.80x

Revenue (TTM)

BDSX$103M

INFU$143M

Revenue Growth (YoY)

BDSX34.5%

INFU2.5%

Forward Rev Growth

BDSX20.2%

INFU6.2%

Gross Margin (TTM)

BDSX82.5%

INFU57.5%

Operating Margin (TTM)

BDSX0.0%

INFU9.3%

EBITDA Margin (TTM)

BDSX-14.6%

INFU18.4%

Net Margin (TTM)

BDSX-27.0%

INFU6.0%

FCF Margin (TTM)

BDSX-19.8%

INFU8.8%

Net Income (TTM)

BDSX$-28M

INFU$9M

FCF (TTM)

BDSX$-20M

INFU$13M

EPS (TTM)

BDSX-$2.70

INFU$0.41

ROE (TTM)

BDSX-16487.0%

INFU14.8%

ROA (TTM)

BDSX-3033.0%

INFU8.6%

ROIC (TTM)

BDSX-2700.0%

INFU11.0%

Cash

BDSX$30M

INFU$964K

Debt

BDSX$47M

INFU$20M

Net Cash/Debt

BDSX$-17M

INFU$-19M

Current Ratio (TTM)

BDSX2.85x

INFU2.50x

Quick Ratio (TTM)

BDSX2.85x

INFU2.14x

Debt/Equity (TTM)

BDSX5.12x

INFU0.35x

Debt/Assets (TTM)

BDSX0.0%

INFU0.0%

Interest Coverage (TTM)

BDSXN/A

INFUN/A

Net Debt/EBITDA (TTM)

BDSX0.00x

INFU0.00x

Beta

BDSX0.60

INFU1.43

52W Performance

BDSX224.2%

INFU47.5%

YTD Performance

BDSX271.4%

INFU62.1%

% from 52W High

BDSX-25.0%

INFU-1.8%

% from 52W Low

BDSX356.1%

INFU86.6%

Asset Turnover (TTM)

BDSX1.12x

INFU1.45x

FCF Yield (TTM)

BDSX-8.2%

INFU4.6%

Earnings Yield (TTM)

BDSX-11.2%

INFU3.1%

Dividend Yield (TTM)

BDSXN/A

INFUN/A

Rule of 40

BDSX14.6

INFU11.2

EV/GP/RG

BDSX0.15

INFU0.58

Ticker research

View BDSX research View INFU research

Metric	BDSX Biodesix Inc	INFU InfuSystem Holdings Inc
Market & Valuation
Market Cap	$249M	$274M
Enterprise Value	$265M	$294M
Price	$23.99	$13.60
P/E Ratio	N/A	33.30x
P/S Ratio	2.41x	1.91x
EV/Sales	2.58x	2.05x
EV/EBITDA	0.00x	11.16x
P/B Ratio	30.02x	4.57x
P/FCF Ratio	N/A	21.87x
EV/FCF	-13.01x	23.42x
PEG Ratio	N/A	0.46x
Forward P/E (NTM)	N/A	27.59x
Forward P/S (NTM)	2.00x	1.80x
Revenue & Growth
Revenue (TTM)	$103M	$143M
Revenue Growth (YoY)	34.5%	2.5%
Forward Rev Growth	20.2%	6.2%
Profitability
Gross Margin (TTM)	82.5%	57.5%
Operating Margin (TTM)	0.0%	9.3%
EBITDA Margin (TTM)	-14.6%	18.4%
Net Margin (TTM)	-27.0%	6.0%
FCF Margin (TTM)	-19.8%	8.8%
Net Income (TTM)	$-28M	$9M
FCF (TTM)	$-20M	$13M
EPS (TTM)	-$2.70	$0.41
ROE (TTM)	-16487.0%	14.8%
ROA (TTM)	-3033.0%	8.6%
ROIC (TTM)	-2700.0%	11.0%
Financial Health
Cash	$30M	$964K
Debt	$47M	$20M
Net Cash/Debt	$-17M	$-19M
Current Ratio (TTM)	2.85x	2.50x
Quick Ratio (TTM)	2.85x	2.14x
Debt/Equity (TTM)	5.12x	0.35x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.60	1.43
52W Performance	224.2%	47.5%
YTD Performance	271.4%	62.1%
% from 52W High	-25.0%	-1.8%
% from 52W Low	356.1%	86.6%
Efficiency & Yields
Asset Turnover (TTM)	1.12x	1.45x
FCF Yield (TTM)	-8.2%	4.6%
Earnings Yield (TTM)	-11.2%	3.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	14.6	11.2
EV/GP/RG	0.15	0.58
Ticker research	View BDSX research	View INFU research